Notable and Newsworthy

Stay informed about the latest developments in our science and clinical progress:

Partnerships & investments — strategic backing to accelerate discovery and development.
Scientific milestones — discoveries that expand our therapeutic horizons.
Clinical advancements — progress toward meaningful impact for patients.

CORE Biomedicine Signs Exclusive Licensing Agreement with Eisai for Precision Oncology Programs

CORE Biomedicine, an innovative drug discovery company developing next-generation precision medicines for broader populations of cancer patients, announced a licensing agreement with Eisai Co., Ltd., granting CORE exclusive global rights to develop and commercialize multiple preclinical oncology programs.

Jul 28, 2026

Press Releases

CORE Biomedicine Secures $21 Million Series A Venture Financing and Receives AMED Grant Award to Advance Novel Cancer Therapeutics

CORE Biomedicine, a biotechnology company pioneering lineage-based precision oncology therapeutics, today announced the completion of a $21 million Series A financing.

Jul 28, 2026

Press Releases

CORE Biomedicine, Inc. Selected to Present at the 2025 ALIGN Summit Hosted by MassBio

CORE Biomedicine, Inc. is proud to announce its selection as a presenting company at the prestigious 2025 ALIGN Summit, an annual life sciences innovation and partnering conference hosted by the Massachusetts Biotechnology Council (MassBio).

Sep 15, 2025

Press Releases

CORE Biomedicine, Inc. Selected to Present at LUMINESCENCE During the 2025 BIO Convention in Boston, MA

CORE Biomedicine, Inc., an innovative biotechnology company advancing transformative approaches in oncology, is honored to announce its acceptance to present at LUMINESCENCE, a key industry showcase within the 2025 BIO Convention.

Jun 1, 2025

Press Releases

CORE Biomedicine, Inc. Named Finalist in the 2025 Harvard Presidents Innovation Challenge

CORE Biomedicine, Inc. is proud to announce that it has been selected as an official Finalist in the prestigious 2025 Harvard Presidents Innovation Challenge.

May 27, 2025